INDEX 343oral antidiabetic agents, see alsoalpha-glucosidase <strong>in</strong>hibitors; metform<strong>in</strong>,frequency of hypoglycaemia;sulphonylureas; thiazolid<strong>in</strong>edioneshypoglycaemic effects, 247–252compared with <strong>in</strong>sul<strong>in</strong> therapy, 251–253oxytoc<strong>in</strong>, changes dur<strong>in</strong>g hypoglycaemia, 13,14–15pallor (cl<strong>in</strong>ical sign), 17palpitations (symptom), 30, 31, 36, 196difficulty <strong>in</strong> <strong>in</strong>terpret<strong>in</strong>g, 37pancreas, hormonal changes dur<strong>in</strong>ghypoglycaemia, 13, 15, 21pancreatic polypeptide, changes dur<strong>in</strong>ghypoglycaemia, 13, 15parasympathetic nervous system, 10, 11activation dur<strong>in</strong>g hypoglycaemia, 12, 143passenger carry<strong>in</strong>g vehicle (PCV) licences,320, 324patient ‘error’, as ‘cause’ of hypoglycaemia, 62,103peripheral autonomic neuropathyand impaired awareness of hypoglycaemia,152–153and severe hypoglycaemia, 73–74, 110pessimism dur<strong>in</strong>g hypoglycaemia, 43, 312phobia about hypoglycaemia, 43, 312physical activity (children)management of, 208–209as risk factor, 200–201physical exhaustion, and hypoglycaemia, 317physically demand<strong>in</strong>g jobs, and strict glycaemiccontrol, 185physiological responses to hypoglycaemia,15–20, 142, 143pituitary failure, 130pituitary function, effect of hypoglycaemia, 13pituitary gland, hormonal changes dur<strong>in</strong>ghypoglycaemia, 13–15, 21, 124placenta, <strong>in</strong> mother with diabetes, 218police custody, hypoglycaemia while <strong>in</strong>,327–329positron emission tomography (PET), bra<strong>in</strong>metabolism studies, 6, 132, 161, 177post-mortem diagnosis, 266–269posterior pituitary gland, hormonal changesdur<strong>in</strong>g hypoglycaemia, 13, 14–15postprandial metabolic pathways, 3, 4posture, counterregulatory responses affectedby, 87potassium levels, fall due to hypoglycaemia,273, 276‘pound<strong>in</strong>g’ heart (symptom), 26, 29, 31, 142,143children, 32older people, 240<strong>in</strong> pregnancy, 221prandial glucose regulators, 249pregnancy, see also diabetic pregnancyaverage age of mothers with diabetes, 217frequency of hypoglycaemia, 219–222lifestyle management <strong>in</strong>, 229maternal complications due to diabetes,230–231metabolic changes dur<strong>in</strong>g, 217–219organisation of cl<strong>in</strong>ical care, 223–226pre-conception care/counsell<strong>in</strong>g, 223prevalence of hypoglycaemiamild hypoglycaemia, 54, 246nocturnal hypoglycaemia, 83, 193, 196severe hypoglycaemia, 121, 198<strong>in</strong> pregnancy, 220, 227<strong>in</strong> type 2 diabetes, 253, 256previous history of hypoglycaemia, see alsoantecedent hypoglycaemiaas risk factor, 64, 68, 69, 102, 157–160<strong>in</strong> pregnancy, 221and worry, 44prison, management of diabetes <strong>in</strong>, 330–331prison officer, as restricted occupation, 326profound hypoglycaemiacounterregulatory responses, 134hepatic autoregulation <strong>in</strong>, 9<strong>in</strong>creased cerebral blood flow <strong>in</strong>, 123prolact<strong>in</strong>, changes dur<strong>in</strong>g hypoglycaemia, 13, 14prospective studiescompared with retrospective studies, 51–52,172mild hypoglycaemia, 53, 54–55severe hypoglycaemia, 57, 58, 59children, 194 195, 286type 2 diabetes, 248−249,253, 254prote<strong>in</strong> snack, and nocturnal hypoglycaemia, 93psychiatric disturbance/illnesseffect of hypoglycaemia, 295as risk factor for death, 58, 269treatment of, 281psychological consequences of hypoglycaemia,311
344 INDEXpsychological factors, and risk ofhypoglycaemia, 74psychosocial manifestations of hypoglycaemia,290, 310–312reaction time, effect of hypoglycaemia, 38, 39reactions to hypoglycaemia, 142, see alsosymptoms of hypoglycaemiarebound hyperglycaemia, 90–91cl<strong>in</strong>ical approach, 92recreational activities, 317regional blood flow, changes dur<strong>in</strong>ghypoglycaemia, 16–18ren<strong>in</strong>, changes dur<strong>in</strong>g hypoglycaemia, 15repagl<strong>in</strong>ide, 249ret<strong>in</strong>opathy<strong>in</strong> diabetic pregnancy, 227, 232effect of hypoglycaemia, 73, 279reduction <strong>in</strong> prevalence, 122and strict glycaemic control, 184retrospective studiescompared with prospective studies, 51–52,172mild hypoglycaemia, 52, 53severe hypoglycaemia, 57, 58, 59, 66<strong>in</strong> children, 196, 205type 2 diabetes, 248−249, 252, 254risk factorsfor hypoglycaemia, 63–75, 101–103, 161,173–177<strong>in</strong> children, 197–202for severe hypoglycaemia, 63–75, 149, 161,173–177for sudden death, 272–275road traffic accidents (RTAs),hypoglycaemia-<strong>in</strong>duced, 319–320rosiglitazone, 247school exam<strong>in</strong>ations, 326–327schools, emergency treatment arrangements, 328Scottish <strong>Diabetes</strong> <strong>in</strong> Pregnancy Study, 219, 220severe hypoglycaemiadef<strong>in</strong>itions, 51, 51, 172, 193, 220, 246, 286effect of <strong>in</strong>tensive <strong>in</strong>sul<strong>in</strong> therapy, 63–67,173–177, 287<strong>in</strong> children and adolescents, 199–200, 208emergency service <strong>in</strong>volvement, 58, 256–257fear of future episodes, 74, 311, 312frequency, 57–60, 196children, 192−193pregnant women, 219, 220hospital referrals, 58, 60, 115, 116management of, 115–116, 208neuropsychological deterioration due to,287–290rates (1992–2002), 121, 123, 198risk factors, 63–75, 149, 161, 173–177sulphonylurea therapy, 247type 2 diabetescompared with type 1 diabetes, 256<strong>in</strong>sul<strong>in</strong> therapy, 253–256oral antidiabetic agents, 247, 250without warn<strong>in</strong>g symptoms, 65, 147, 162and duration of <strong>in</strong>sul<strong>in</strong> therapy, 69, 147severe neuroglycopenia, blood glucosethreshold, 142shak<strong>in</strong>g, see trembl<strong>in</strong>g (symptom)shift work, 325–326s<strong>in</strong>gle photon emission [computed] tomography(SPE[C]T)bra<strong>in</strong> imag<strong>in</strong>g study, 287cerebral blood flow studies, 16, 297sk<strong>in</strong>, changes <strong>in</strong> blood flow dur<strong>in</strong>ghypoglycaemia, 17sleep, counterregulatory responses affected by,73, 87–88, 203sleep patternscounterregulatory response affected by, 88,203effect of caffe<strong>in</strong>e, 110sleep<strong>in</strong>ess (symptom), 26, 36see also drows<strong>in</strong>ess (symptom)smok<strong>in</strong>g, risk of hypoglycaemia affected by, 75socio-economic factors, risk of hypoglycaemiaaffected by, 74somatostat<strong>in</strong>action of, 8, 14, 15changes dur<strong>in</strong>g hypoglycaemia, 13, 15Somogyi phenomenon, 90–91, 206speech difficulty (symptom), 26, 30, 31, 36, 196children, 32older people, 240spleen, changes <strong>in</strong> blood flow dur<strong>in</strong>ghypoglycaemia, 17, 18sport<strong>in</strong>g activities, 315–317Stockholm <strong>Diabetes</strong> Intervention Study (SDIS),64, 65, 66, 289strenuous exercise, 313, 314, 315, 317strict glycaemic control, see also <strong>in</strong>tensive<strong>in</strong>sul<strong>in</strong> therapycontra<strong>in</strong>dications, 184and fear of hypoglycaemia, 121, 310
- Page 2 and 3:
Hypoglycaemia in Clinical DiabetesS
- Page 4 and 5:
Hypoglycaemia in Clinical DiabetesS
- Page 6:
ToEmily, Ben and Marc
- Page 9 and 10:
viiiCONTENTS13 Long-term Effects of
- Page 12 and 13:
ContributorsProfessor Stephanie A.
- Page 14 and 15:
1 Normal Glucose Metabolismand Resp
- Page 16 and 17:
NORMAL GLUCOSE HOMEOSTASIS 3Box 1.2
- Page 18 and 19:
Fed state (Figure 1.1b)EFFECTS OF G
- Page 20 and 21:
COUNTERREGULATION DURING HYPOGLYCAE
- Page 22 and 23:
COUNTERREGULATION DURING HYPOGLYCAE
- Page 24 and 25:
HORMONAL CHANGES DURING HYPOGLYCAEM
- Page 26 and 27:
HORMONAL CHANGES DURING HYPOGLYCAEM
- Page 28 and 29:
PHYSIOLOGICAL RESPONSES 15hormones.
- Page 30 and 31:
PHYSIOLOGICAL RESPONSES 17Figure 1.
- Page 32 and 33:
PHYSIOLOGICAL RESPONSES 19We do not
- Page 34 and 35:
REFERENCES 21NORMAL GLUCOSE HOMEOST
- Page 36 and 37:
REFERENCES 23Hamilton-Wessler M, Be
- Page 38 and 39:
2 Symptoms of Hypoglycaemiaand Effe
- Page 40 and 41:
SYMPTOMS OF HYPOGLYCAEMIA 27appeare
- Page 42 and 43:
SYMPTOMS OF HYPOGLYCAEMIA 29aware o
- Page 44 and 45:
SYMPTOMS OF HYPOGLYCAEMIA 31Table 2
- Page 46 and 47:
SYMPTOMS OF HYPOGLYCAEMIA 33frequen
- Page 48 and 49:
SYMPTOMS OF HYPOGLYCAEMIA 35Figure
- Page 50 and 51:
ACUTE HYPOGLYCAEMIA AND COGNITIVE F
- Page 52 and 53:
ACUTE HYPOGLYCAEMIA AND COGNITIVE F
- Page 54 and 55:
ACUTE HYPOGLYCAEMIA AND COGNITIVE F
- Page 56 and 57:
ACUTE HYPOGLYCAEMIA AND EMOTIONS 43
- Page 58 and 59:
REFERENCES 45Bremer JP, Baron M, Pe
- Page 60 and 61:
REFERENCES 47McAulay V, Deary IJ, F
- Page 62 and 63:
3 Frequency, Causes and RiskFactors
- Page 64 and 65:
FREQUENCY OF HYPOGLYCAEMIA 51Box 3.
- Page 66 and 67:
Table 3.1 Frequency of mild hypogly
- Page 68 and 69:
FREQUENCY OF HYPOGLYCAEMIA 55some i
- Page 70 and 71:
FREQUENCY OF HYPOGLYCAEMIA 57Jansse
- Page 72 and 73:
Table 3.2 Frequency of severe hypog
- Page 74 and 75:
CAUSES OF HYPOGLYCAEMIACAUSES OF HY
- Page 76 and 77:
RISK FACTORS FOR SEVERE HYPOGLYCAEM
- Page 78 and 79:
RISK FACTORS FOR SEVERE HYPOGLYCAEM
- Page 80 and 81:
RISK FACTORS FOR SEVERE HYPOGLYCAEM
- Page 82 and 83:
RISK FACTORS FOR SEVERE HYPOGLYCAEM
- Page 84 and 85:
RISK FACTORS FOR SEVERE HYPOGLYCAEM
- Page 86 and 87:
RISK FACTORS FOR SEVERE HYPOGLYCAEM
- Page 88 and 89:
CONCLUSIONS 75Other Risk FactorsThe
- Page 90 and 91:
REFERENCES 77Bott S, Bott U, Berger
- Page 92 and 93:
REFERENCES 79Leckie AM, Graham MK,
- Page 94:
REFERENCES 81Vervoort G, Goldschmid
- Page 97 and 98:
Table 4.1 Frequency of nocturnal hy
- Page 99 and 100:
86 NOCTURNAL HYPOGLYCAEMIACAUSES OF
- Page 101 and 102:
88 NOCTURNAL HYPOGLYCAEMIAPlasma Ep
- Page 103 and 104:
90 NOCTURNAL HYPOGLYCAEMIACAN NOCTU
- Page 105 and 106:
92 NOCTURNAL HYPOGLYCAEMIABox 4.2 C
- Page 107 and 108:
94 NOCTURNAL HYPOGLYCAEMIAconflicti
- Page 109 and 110:
96 NOCTURNAL HYPOGLYCAEMIA• Noctu
- Page 111 and 112:
98 NOCTURNAL HYPOGLYCAEMIAHolleman
- Page 114 and 115:
5 Moderators, Monitoring andManagem
- Page 116 and 117:
LIFESTYLE MODERATORS 103• absolut
- Page 118 and 119:
LIFESTYLE MODERATORS 10520 22 24 2
- Page 120 and 121:
LIFESTYLE MODERATORS 107Growthhormo
- Page 122 and 123:
LIFESTYLE MODERATORS 109mean change
- Page 124 and 125:
MONITORING 111flow) while simultane
- Page 126 and 127:
MONITORING 113• It is unclear whe
- Page 128 and 129:
MANAGEMENT OF HYPOGLYCAEMIA 115MANA
- Page 130 and 131:
REFERENCES 117CONCLUSIONS• Hypogl
- Page 132 and 133:
REFERENCES 119MacDonald MJ (1987).
- Page 134 and 135:
6 Counterregulatory Deficienciesin
- Page 136 and 137:
NORMAL GLUCOSE COUNTERREGULATION 12
- Page 138 and 139:
NORMAL GLUCOSE COUNTERREGULATION 12
- Page 140 and 141:
DEFECTIVE HORMONAL GLUCOSE COUNTERR
- Page 142 and 143:
DEFECTIVE HORMONAL GLUCOSE COUNTERR
- Page 144 and 145:
MECHANISMS OF COUNTERREGULATORY FAI
- Page 146 and 147:
AGE, OBESITY AND GLUCOSE COUNTERREG
- Page 148 and 149:
TREATMENT OF COUNTERREGULATORY FAIL
- Page 150 and 151:
REFERENCES 137Bingham EM, Dunn JT,
- Page 152 and 153:
REFERENCES 139McCall AL, Fixman LB,
- Page 154 and 155:
7 Impaired Awareness ofHypoglycaemi
- Page 156 and 157:
NORMAL RESPONSES TO HYPOGLYCAEMIA 1
- Page 158 and 159:
IMPAIRED AWARENESS OF HYPOGLYCAEMIA
- Page 160 and 161:
PREVALENCE OF IMPAIRED AWARENESS OF
- Page 162 and 163:
PATHOGENESIS OF IMPAIRED AWARENESS
- Page 164 and 165:
PATHOGENESIS OF IMPAIRED AWARENESS
- Page 166 and 167:
PATHOGENESIS OF IMPAIRED AWARENESS
- Page 168 and 169:
PATHOGENESIS OF IMPAIRED AWARENESS
- Page 170 and 171:
PATHOGENESIS OF IMPAIRED AWARENESS
- Page 172 and 173:
Table 7.3 Studies of antecedent hyp
- Page 174 and 175:
IMPAIRED AWARENESS OF HYPOGLYCAEMIA
- Page 176 and 177:
TREATMENT STRATEGIES 163or unexplai
- Page 178 and 179:
CONCLUSIONS 165Box 7.5 Treatment st
- Page 180 and 181:
REFERENCES 167Boyle PJ (1997). Alte
- Page 182 and 183:
REFERENCES 169Kerr D, Sherwin RS, P
- Page 184 and 185:
8 Risks of Strict GlycaemicControlS
- Page 186 and 187:
CONTRIBUTORS TO INCREASED RISK OF S
- Page 188 and 189:
CONTRIBUTORS TO INCREASED RISK OF S
- Page 190 and 191:
CEREBRAL ADAPTATION 177severe, are
- Page 192 and 193:
CEREBRAL ADAPTATION 179hypoglycaemi
- Page 194 and 195:
THERAPEUTIC MANIPULATION 181Figure
- Page 196 and 197:
PATIENTS UNSUITABLE FOR STRICT CONT
- Page 198 and 199:
REFERENCES 185It is the patient who
- Page 200 and 201:
REFERENCES 187Egger M, Davey Smith
- Page 202:
REFERENCES 189Simonson DC, Tamborla
- Page 205 and 206:
192 HYPOGLYCAEMIA IN CHILDREN WITH
- Page 207 and 208:
Table 9.2 Summary of studies examin
- Page 209 and 210:
196 HYPOGLYCAEMIA IN CHILDREN WITH
- Page 211 and 212:
198 HYPOGLYCAEMIA IN CHILDREN WITH
- Page 213 and 214:
200 HYPOGLYCAEMIA IN CHILDREN WITH
- Page 215 and 216:
202 HYPOGLYCAEMIA IN CHILDREN WITH
- Page 217 and 218:
204 HYPOGLYCAEMIA IN CHILDREN WITH
- Page 219 and 220:
206 HYPOGLYCAEMIA IN CHILDREN WITH
- Page 221 and 222:
208 HYPOGLYCAEMIA IN CHILDREN WITH
- Page 223 and 224:
210 HYPOGLYCAEMIA IN CHILDREN WITH
- Page 225 and 226:
212 HYPOGLYCAEMIA IN CHILDREN WITH
- Page 227 and 228:
214 HYPOGLYCAEMIA IN CHILDREN WITH
- Page 230 and 231:
10 Hypoglycaemia in PregnancyAnn E.
- Page 232 and 233:
FREQUENCY OF HYPOGLYCAEMIA IN DIABE
- Page 234 and 235:
FREQUENCY OF HYPOGLYCAEMIA IN DIABE
- Page 236 and 237:
CLINICAL MANAGEMENT BEFORE AND DURI
- Page 238 and 239:
Figure 10.2 Example of home blood g
- Page 240 and 241:
CLINICAL MANAGEMENT BEFORE AND DURI
- Page 242 and 243:
CLINICAL MANAGEMENT BEFORE AND DURI
- Page 244 and 245:
MATERNAL COMPLICATIONS OF DIABETES
- Page 246 and 247:
COMPLICATIONS IN THE INFANT OF THE
- Page 248 and 249:
REFERENCES 235Akazawa M, Akazawa S,
- Page 250:
REFERENCES 237Ray JG, O’Brien TE,
- Page 253 and 254:
240 HYPOGLYCAEMIA IN TYPE 2 DIABETE
- Page 255 and 256:
242 HYPOGLYCAEMIA IN TYPE 2 DIABETE
- Page 257 and 258:
244 HYPOGLYCAEMIA IN TYPE 2 DIABETE
- Page 259 and 260:
246 HYPOGLYCAEMIA IN TYPE 2 DIABETE
- Page 261 and 262:
Table 11.2a Prevalence of severe hy
- Page 263 and 264:
250 HYPOGLYCAEMIA IN TYPE 2 DIABETE
- Page 265 and 266:
252 HYPOGLYCAEMIA IN TYPE 2 DIABETE
- Page 267 and 268:
254 HYPOGLYCAEMIA IN TYPE 2 DIABETE
- Page 269 and 270:
256 HYPOGLYCAEMIA IN TYPE 2 DIABETE
- Page 271 and 272:
258 HYPOGLYCAEMIA IN TYPE 2 DIABETE
- Page 273 and 274:
260 HYPOGLYCAEMIA IN TYPE 2 DIABETE
- Page 275 and 276:
262 HYPOGLYCAEMIA IN TYPE 2 DIABETE
- Page 277 and 278:
264 HYPOGLYCAEMIA IN TYPE 2 DIABETE
- Page 279 and 280:
266 MORTALITY, CARDIOVASCULAR MORBI
- Page 281 and 282:
268 MORTALITY, CARDIOVASCULAR MORBI
- Page 283 and 284:
270 MORTALITY, CARDIOVASCULAR MORBI
- Page 285 and 286:
272 MORTALITY, CARDIOVASCULAR MORBI
- Page 287 and 288:
274 MORTALITY, CARDIOVASCULAR MORBI
- Page 289 and 290:
276 MORTALITY, CARDIOVASCULAR MORBI
- Page 291 and 292:
278 MORTALITY, CARDIOVASCULAR MORBI
- Page 293 and 294:
280 MORTALITY, CARDIOVASCULAR MORBI
- Page 295 and 296:
282 MORTALITY, CARDIOVASCULAR MORBI
- Page 298 and 299:
13 Long-term Effects ofHypoglycaemi
- Page 300 and 301:
COGNITIVE FUNCTION AND HYPOGLYCAEMI
- Page 302 and 303:
FUNCTIONAL EFFECTS OF HYPOGLYCAEMIA
- Page 304 and 305:
FUNCTIONAL EFFECTS OF HYPOGLYCAEMIA
- Page 306 and 307: FUNCTIONAL EFFECTS OF HYPOGLYCAEMIA
- Page 308 and 309: STRUCTURAL AND FUNCTIONAL CHANGES I
- Page 310 and 311: STRUCTURAL AND FUNCTIONAL CHANGES I
- Page 312 and 313: STRUCTURAL AND FUNCTIONAL CHANGES I
- Page 314 and 315: STRUCTURAL AND FUNCTIONAL CHANGES I
- Page 316 and 317: REFERENCES 303disease (Fisher and F
- Page 318 and 319: REFERENCES 305Fisher M, Frier BM (1
- Page 320: REFERENCES 307Seidl R, Birnbacher R
- Page 323 and 324: 310 LIVING WITH HYPOGLYCAEMIAPSYCHO
- Page 325 and 326: 312 LIVING WITH HYPOGLYCAEMIABox 14
- Page 327 and 328: 314 LIVING WITH HYPOGLYCAEMIAprophy
- Page 329 and 330: 316 LIVING WITH HYPOGLYCAEMIAMost t
- Page 331 and 332: 318 LIVING WITH HYPOGLYCAEMIAfor pu
- Page 333 and 334: 320 LIVING WITH HYPOGLYCAEMIAVocati
- Page 335 and 336: 322 LIVING WITH HYPOGLYCAEMIAif the
- Page 337 and 338: 324 LIVING WITH HYPOGLYCAEMIAestabl
- Page 339 and 340: 326 LIVING WITH HYPOGLYCAEMIAwith g
- Page 341 and 342: 328 LIVING WITH HYPOGLYCAEMIAalcoho
- Page 343 and 344: 330 LIVING WITH HYPOGLYCAEMIAChante
- Page 345 and 346: 332 LIVING WITH HYPOGLYCAEMIASonger
- Page 347 and 348: 334 INDEXanterior pituitary gland,
- Page 349 and 350: 336 INDEXcomplications due to diabe
- Page 351 and 352: 338 INDEXemployment aspects, 323-32
- Page 353 and 354: 340 INDEXhypopituitarism, 74, 102,
- Page 355: 342 INDEXmood changes due to hypogl
- Page 359: 346 INDEXtrain drivers, 323, 324tra